Do Smokers' Perceptions of the Harmfulness of Nicotine Replacement Therapy and Nicotine Vaping Products as Compared to Cigarettes Influence Their Use as an Aid for Smoking Cessation? Findings from the ITC Four Country Smoking and Vaping Surveys
- PMID: 35368082
- PMCID: PMC9356684
- DOI: 10.1093/ntr/ntac087
Do Smokers' Perceptions of the Harmfulness of Nicotine Replacement Therapy and Nicotine Vaping Products as Compared to Cigarettes Influence Their Use as an Aid for Smoking Cessation? Findings from the ITC Four Country Smoking and Vaping Surveys
Abstract
Introduction: This study examined whether smokers' harm perceptions of nicotine replacement therapy (NRT) and nicotine vaping products (NVPs) relative to cigarettes predicted their subsequent use as smoking cessation aids during their last quit attempt (LQA).
Aims and methods: We analyzed data from 1,315 current daily smokers (10+ cigarettes per day) who were recruited at Wave 1 (2016), and who reported making a quit attempt by Wave 2 (2018) of the International Tobacco Control Four Country Smoking and Vaping Surveys in Australia, Canada, England, and the United States. We used multinomial logistic regression models to examine prospective associations between harm perceptions of (a) NRT and (b) NVPs and their use at LQA, controlling for socio-demographic and other potential confounders.
Results: Smokers who perceive that (a) NRT and (b) NVPs are much less harmful than cigarettes were more likely to subsequently use the respective product as an aid than using no aid or other aids during LQA (adjusted relative risk ratio [aRRR] = 3.79, 95%CI = 2.16-6.66; and aRRR = 2.11, 95%CI = 1.29-3.45, respectively) compared to smokers who perceive these products as equally or more harmful. Additionally, those who perceive NVPs as much less harmful than cigarettes were less likely to use NRT as a quit aid (aRRR = 0.34, 95%CI = 0.20-0.60). No country variations for these associations were found.
Conclusions: This study found that smokers' perceptions of the harmfulness of (a) NRT and (b) NVPs relative to cigarettes predicted the respective product use when trying to quit smoking. Corrective education targeting misperceptions of nicotine products' relative harmfulness may facilitate their use for smoking cessation.
Implications: Nicotine replacement therapy and nicotine vaping products are two commonly used smoking cessation aids. This study demonstrates that misperceptions of the harms of nicotine products relative to cigarettes influence their use for smoking cessation. Believing that nicotine vaping products are much less harmful than cigarette smoking may lead some smokers to prefer these products over nicotine replacement therapy to aid smoking cessation. Education targeting misperceptions of nicotine products' harmfulness relative to cigarettes may enable smokers to make informed choices about which are appropriate to aid smoking cessation.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.
Figures
Similar articles
-
Individual and Conjoint Factors Associated With Beliefs About the Harmfulness of Nicotine Replacement Therapies Relative to Combustible Cigarettes Among People Who Smoke: Findings From the 2020 ITC Four Country Smoking and Vaping Survey.Nicotine Tob Res. 2023 Aug 19;25(9):1594-1602. doi: 10.1093/ntr/ntad075. Nicotine Tob Res. 2023. PMID: 37195899 Free PMC article.
-
Self-Reported Quit Aids and Assistance Used By Smokers At Their Most Recent Quit Attempt: Findings from the 2020 International Tobacco Control Four Country Smoking and Vaping Survey.Nicotine Tob Res. 2021 Aug 29;23(10):1699-1707. doi: 10.1093/ntr/ntab068. Nicotine Tob Res. 2021. PMID: 33837435 Free PMC article.
-
Identifying factors that conjointly influence nicotine vaping product relative harm perception among smokers and recent ex-smokers: Findings from the 2016 ITC Four Country Smoking and Vaping Survey.Drug Alcohol Depend. 2021 Jan 1;218:108370. doi: 10.1016/j.drugalcdep.2020.108370. Epub 2020 Oct 20. Drug Alcohol Depend. 2021. PMID: 33139154 Free PMC article.
-
How do consumers perceive differences in risk across nicotine products? A review of relative risk perceptions across smokeless tobacco, e-cigarettes, nicotine replacement therapy and combustible cigarettes.Tob Control. 2017 Mar;26(e1):e49-e58. doi: 10.1136/tobaccocontrol-2016-053060. Epub 2016 Sep 13. Tob Control. 2017. PMID: 27625408 Review.
-
Factors influencing the uptake and use of nicotine replacement therapy and e-cigarettes in pregnant women who smoke: a qualitative evidence synthesis.Cochrane Database Syst Rev. 2020 May 22;5(5):CD013629. doi: 10.1002/14651858.CD013629. Cochrane Database Syst Rev. 2020. PMID: 32441810 Free PMC article.
Cited by
-
Variation in Relative Risk Perceptions and Tobacco Use by Race and Socioeconomic Status Among Older Adults Who Smoke: Evidence From the Population Assessment of Tobacco and Health Study.Nicotine Tob Res. 2025 Jun 23;27(7):1168-1176. doi: 10.1093/ntr/ntae242. Nicotine Tob Res. 2025. PMID: 39404138
-
Perceptions of harmfulness of heated tobacco and nicotine vaping products compared to cigarettes, and the association of advertising exposure on harm perceptions among adults who smoke in South Korea: Cross-sectional findings from the 2020 ITC Korea Survey.Tob Induc Dis. 2023 Sep 28;21:121. doi: 10.18332/tid/170252. eCollection 2023. Tob Induc Dis. 2023. PMID: 37781238 Free PMC article.
-
Why can't smokers quit? Longitudinal study of smokers in the US using the Population Assessment of Tobacco and Health (PATH) waves 1 to 5.Addict Behav Rep. 2023 Oct 21;18:100517. doi: 10.1016/j.abrep.2023.100517. eCollection 2023 Dec. Addict Behav Rep. 2023. PMID: 37955038 Free PMC article.
-
Harm perceptions across vaping product features: An on-line cross-sectional survey of adults who smoke and/or vape in the United Kingdom.Addiction. 2025 Mar;120(3):524-538. doi: 10.1111/add.16572. Epub 2024 Jun 5. Addiction. 2025. PMID: 38839597 Free PMC article.
-
Individual and Conjoint Factors Associated With Beliefs About the Harmfulness of Nicotine Replacement Therapies Relative to Combustible Cigarettes Among People Who Smoke: Findings From the 2020 ITC Four Country Smoking and Vaping Survey.Nicotine Tob Res. 2023 Aug 19;25(9):1594-1602. doi: 10.1093/ntr/ntad075. Nicotine Tob Res. 2023. PMID: 37195899 Free PMC article.
References
-
- Czoli CD, Fong GT, Mays D, Hammond D.. How do consumers perceive differences in risk across nicotine products? A review of relative risk perceptions across smokeless tobacco, e-cigarettes, nicotine replacement therapy and combustible cigarettes. Tob Control. 2017;26(e1):e49–e58. - PubMed
-
- National Academies of Sciences Engineering and Medicine. Public health consequences of e-cigarettes. Washington, DC: The National Academies Press; 2018. http://nationalacademies.org/hmd/Reports/2018/public-health-consequences... - PubMed
-
- Royal College of Physicians. Nicotine without smoke: Tobacco harm reduction. London: RCP; 2016.
-
- Gravely S, Cummings KM, Hammond D, et al. . Self-reported quit aids and assistance used by smokers at their most recent quit attempt: Findings from the 2020 International Tobacco Control Four Country Smoking and Vaping Survey. Nicotine Tob Res. 2021;23(10):1699–1707. doi:10.1093/ntr/ntab068. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical